Nasdaq5d
Scilex Holding Company Reports ZTlido® Associated with Reduced Opioid Use Compared to 5% Lidocaine Patch in Recent Study
In the study, 51.9% of ZTlido® patients experienced decreased or discontinued opioid use, compared to 45.5% with the 5% patch, with more ZTlido® patients reporting at least a 20% reduction in ...
Scilex Holding Company Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% Patch
More patients treated with ZTlido® saw either a decrease or discontinuation of opioid use compared with those treated with the 5% patch (51.9% ...
Scilex announces Pain Medicine News published data on ZTildo vs Lidocaine 5%
Scilex (SCLX) announced that Pain Medicine News published retrospective claims data on ZTlido vs. lidocaine 5% patch. Pain ...
Investing5d
ZTlido patch linked to reduced opioid use in pain study
A key finding indicated that 51.9% of patients treated with ZTlido® experienced either a decrease or a halt in opioid use, compared to 45.5% of those using the 5% lidocaine patch. Furthermore ...
Investing5d
ZTlido patch linked to reduced opioid use in pain study
A key finding indicated that 51.9% of patients treated with ZTlido® experienced either a decrease or a halt in opioid use, compared to 45.5% of those using the 5% lidocaine patch. Furthermore, a ...